Search

everythinglearnresearchcommunity

for

Search:↓

The treatment with valproate, acetylcarnitine, folic acid, and vitamin B12 may improve muscle strength in children with SMA without significant side effects.

Oral dutasteride is effective and safe for treating frontal fibrosing alopecia.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

FA-MNPs effectively targeted and killed cancer cells but didn't overcome drug resistance.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Deferoxamine may help protect inner ear cells from damage caused by oxidative stress.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

A new MTX2 gene mutation caused a severe genetic disorder in a young Chinese girl.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Pemetrexed with cisplatin is safer and more effective than gemcitabine with cisplatin for advanced lung cancer.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Upadacitinib may effectively treat resistant lichen planopilaris.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

Finasteride and dutasteride might lower melanoma risk.